Nature, ISSN 0028-0836, 02/2016, Volume 530, Issue 7589, pp. 228 - 232
The Ebola virus disease epidemic in West Africa is the largest on record, responsible for over 28,599 cases and more than 11,299 deaths(1). Genome sequencing...
TRANSMISSION | VIRUS | EVOLUTION | DNA | MULTIDISCIPLINARY SCIENCES | SIERRA-LEONE | DYNAMICS | OUTBREAK | NANOPORE SEQUENCER | Ebolavirus - classification | Genome, Viral - genetics | Humans | Mutagenesis - genetics | Ebolavirus - pathogenicity | Mutation Rate | Disease Outbreaks - statistics & numerical data | Ebolavirus - genetics | Guinea - epidemiology | Hemorrhagic Fever, Ebola - epidemiology | Sequence Analysis, DNA - instrumentation | Epidemiological Monitoring | Time Factors | Hemorrhagic Fever, Ebola - virology | Aircraft | Sequence Analysis, DNA - methods | Ebola virus | Distribution | Genetic aspects | Nucleotide sequencing | Methods | DNA sequencing | Prevalence studies (Epidemiology) | Electrical currents | Pathogens | Surveillance | Laboratories | Phylogenetics | Universal Serial Bus | Genomes | Bioinformatics | Deoxyribonucleic acid--DNA
TRANSMISSION | VIRUS | EVOLUTION | DNA | MULTIDISCIPLINARY SCIENCES | SIERRA-LEONE | DYNAMICS | OUTBREAK | NANOPORE SEQUENCER | Ebolavirus - classification | Genome, Viral - genetics | Humans | Mutagenesis - genetics | Ebolavirus - pathogenicity | Mutation Rate | Disease Outbreaks - statistics & numerical data | Ebolavirus - genetics | Guinea - epidemiology | Hemorrhagic Fever, Ebola - epidemiology | Sequence Analysis, DNA - instrumentation | Epidemiological Monitoring | Time Factors | Hemorrhagic Fever, Ebola - virology | Aircraft | Sequence Analysis, DNA - methods | Ebola virus | Distribution | Genetic aspects | Nucleotide sequencing | Methods | DNA sequencing | Prevalence studies (Epidemiology) | Electrical currents | Pathogens | Surveillance | Laboratories | Phylogenetics | Universal Serial Bus | Genomes | Bioinformatics | Deoxyribonucleic acid--DNA
Journal Article
2003, Collection Patrimoine architectural, ISBN 9782706817656, 155
Book
American Journal of Ophthalmology, ISSN 0002-9394, 2016, Volume 175, pp. 114 - 121
Abstract Purpose The Ebola outbreak of 2013-2016 severely affected West Africa and resulted in 2544 deaths and 1270 survivors in Guinea, the country where it...
Ophthalmology | NORTHERN CALIFORNIA | LIBERIA | INTRAOCULAR ANTIBODY-SYNTHESIS | RUBELLA-VIRUS | PERSISTENCE | KIKWIT | VIRUS DISEASE | UVEITIS | OPHTHALMOLOGY | PREVALENCE | SEXUAL TRANSMISSION | Ebola virus | Complications and side effects | Ebola virus infections | Cataracts | Epidemics | Mens health | Inflammation | Patients | Age
Ophthalmology | NORTHERN CALIFORNIA | LIBERIA | INTRAOCULAR ANTIBODY-SYNTHESIS | RUBELLA-VIRUS | PERSISTENCE | KIKWIT | VIRUS DISEASE | UVEITIS | OPHTHALMOLOGY | PREVALENCE | SEXUAL TRANSMISSION | Ebola virus | Complications and side effects | Ebola virus infections | Cataracts | Epidemics | Mens health | Inflammation | Patients | Age
Journal Article
2006, Archéologie, ISBN 9782842801229, 335
Book
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 2, pp. 189 - 198
Summary Background Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore...
Infectious Disease | GABON | PARASITES | INFECTIOUS DISEASES | MALI | ARTEMETHER-LUMEFANTRINE | COMBINATION | PLASMODIUM-FALCIPARUM MALARIA | CHILDREN | Guinea | Humans | Middle Aged | Child, Preschool | Infant | Male | Plasmodium - drug effects | Young Adult | Mali | Aged, 80 and over | Adult | Female | Child | Antimalarials - adverse effects | Artemisinins - administration & dosage | Treatment Outcome | Retreatment | Artemisinins - therapeutic use | Burkina Faso | Antimalarials - administration & dosage | Adolescent | Aged | Malaria - drug therapy | Naphthyridines - administration & dosage | Drug Combinations | Drugs | Care and treatment | Malaria | Parasitic diseases | Pharmacy | Drugstores | Epidemiology | Cells | Studies | Enzymes | Mortality | Liver | Human immunodeficiency virus--HIV | Clinical trials | Drug dosages | Public health
Infectious Disease | GABON | PARASITES | INFECTIOUS DISEASES | MALI | ARTEMETHER-LUMEFANTRINE | COMBINATION | PLASMODIUM-FALCIPARUM MALARIA | CHILDREN | Guinea | Humans | Middle Aged | Child, Preschool | Infant | Male | Plasmodium - drug effects | Young Adult | Mali | Aged, 80 and over | Adult | Female | Child | Antimalarials - adverse effects | Artemisinins - administration & dosage | Treatment Outcome | Retreatment | Artemisinins - therapeutic use | Burkina Faso | Antimalarials - administration & dosage | Adolescent | Aged | Malaria - drug therapy | Naphthyridines - administration & dosage | Drug Combinations | Drugs | Care and treatment | Malaria | Parasitic diseases | Pharmacy | Drugstores | Epidemiology | Cells | Studies | Enzymes | Mortality | Liver | Human immunodeficiency virus--HIV | Clinical trials | Drug dosages | Public health
Journal Article
The Lancet, ISSN 0140-6736, 04/2018, Volume 391, Issue 10128, pp. 1378 - 1390
Artemether–lumefantrine and artesunate–amodiaquine are used as first-line artemisinin-based combination therapies (ACTs) in west Africa....
MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | ARTEMETHER-LUMEFANTRINE | AMODIAQUINE | SUSCEPTIBILITY | MEFLOQUINE | COMBINATION | PLASMODIUM-FALCIPARUM MALARIA | FAILURE | CHILDREN | Tablets | Artemisinin | Medical services | Colleges & universities | Clinical trials | Parasites | Developing countries--LDCs | Incidence | Hepatitis | Randomization | Motivation | Vomiting | Comparators | Artesunate | Population | Children | Safety | Dihydroartemisinin | Vector-borne diseases | Medical research | Alanine | Effectiveness | Malaria | Assessments | Patients | Fever | Pregnancy | Pyronaridine | Transaminases | Alanine transaminase | Amodiaquine | Artemether | Adults | Prolongation
MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | ARTEMETHER-LUMEFANTRINE | AMODIAQUINE | SUSCEPTIBILITY | MEFLOQUINE | COMBINATION | PLASMODIUM-FALCIPARUM MALARIA | FAILURE | CHILDREN | Tablets | Artemisinin | Medical services | Colleges & universities | Clinical trials | Parasites | Developing countries--LDCs | Incidence | Hepatitis | Randomization | Motivation | Vomiting | Comparators | Artesunate | Population | Children | Safety | Dihydroartemisinin | Vector-borne diseases | Medical research | Alanine | Effectiveness | Malaria | Assessments | Patients | Fever | Pregnancy | Pyronaridine | Transaminases | Alanine transaminase | Amodiaquine | Artemether | Adults | Prolongation
Journal Article
African Journal of Reproductive Health, ISSN 1118-4841, 2017, Volume 21, Issue 1, pp. 104 - 113
The objective of this study was to document maternal and child health care workers' knowledge, attitudes and practices on service delivery before, during and...
Practices | Maternal and child health | Guinea | Ebola | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | EPIDEMIC | practices | Cross-Sectional Studies | Hemorrhagic Fever, Ebola - prevention & control | Professional Competence | Humans | Guinea - epidemiology | Health Knowledge, Attitudes, Practice | Hemorrhagic Fever, Ebola - epidemiology | Hemorrhagic Fever, Ebola - therapy | Hemorrhagic Fever, Ebola - diagnosis | Rural Population | Health Personnel | Maternal-Child Health Centers - organization & administration | Adult | Disease Outbreaks - prevention & control | Female | Surveys and Questionnaires | Child | Maternal-Child Health Services - manpower | Rural Health Services | Medical personnel | Ebola virus infections | Care and treatment | Research | Beliefs, opinions and attitudes | Epidemics | Global health | Health services | Rural areas | Mortality | Childrens health | Attitudes | Midwifery | Infections | Obstetrics | Ebola virus | Disease prevention | Maternal & child health
Practices | Maternal and child health | Guinea | Ebola | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | EPIDEMIC | practices | Cross-Sectional Studies | Hemorrhagic Fever, Ebola - prevention & control | Professional Competence | Humans | Guinea - epidemiology | Health Knowledge, Attitudes, Practice | Hemorrhagic Fever, Ebola - epidemiology | Hemorrhagic Fever, Ebola - therapy | Hemorrhagic Fever, Ebola - diagnosis | Rural Population | Health Personnel | Maternal-Child Health Centers - organization & administration | Adult | Disease Outbreaks - prevention & control | Female | Surveys and Questionnaires | Child | Maternal-Child Health Services - manpower | Rural Health Services | Medical personnel | Ebola virus infections | Care and treatment | Research | Beliefs, opinions and attitudes | Epidemics | Global health | Health services | Rural areas | Mortality | Childrens health | Attitudes | Midwifery | Infections | Obstetrics | Ebola virus | Disease prevention | Maternal & child health
Journal Article
2013, ISBN 9781842177655, x, 326
Book
PLoS Medicine, ISSN 1549-1277, 03/2016, Volume 13, Issue 3, p. e1001967
Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at...
VIRAL LOAD | MEDICINE, GENERAL & INTERNAL | HEMORRHAGIC-FEVER | PATIENT | INFECTION | T-705 FAVIPIRAVIR | OUTCOMES | CONVALESCENT PLASMA | OUTBREAK | SEVERE SEPSIS | FEATURES | Antiviral Agents - therapeutic use | Guinea | Humans | Child, Preschool | Therapies, Investigational | Infant | Male | RNA, Viral - blood | Treatment Outcome | Amides - therapeutic use | Pyrazines - therapeutic use | Ebolavirus - genetics | Reverse Transcriptase Polymerase Chain Reaction | Viral Load | Feasibility Studies | Young Adult | Hemorrhagic Fever, Ebola - diagnosis | Adolescent | Adult | Female | Historically Controlled Study | Child | Hemorrhagic Fever, Ebola - drug therapy | Antiviral agents | Ebola virus infections | Drug therapy | Patient outcomes | Care and treatment | RNA | Mortality | Genomics | Clinical trials | Hostages | Biosafety | Oral medication | Ethical aspects | Non-governmental organizations | Ebola virus | Virus diseases | Analysis | Health aspects | Studies | Epidemics | Life Sciences | Social Anthropology and ethnology | Humanities and Social Sciences
VIRAL LOAD | MEDICINE, GENERAL & INTERNAL | HEMORRHAGIC-FEVER | PATIENT | INFECTION | T-705 FAVIPIRAVIR | OUTCOMES | CONVALESCENT PLASMA | OUTBREAK | SEVERE SEPSIS | FEATURES | Antiviral Agents - therapeutic use | Guinea | Humans | Child, Preschool | Therapies, Investigational | Infant | Male | RNA, Viral - blood | Treatment Outcome | Amides - therapeutic use | Pyrazines - therapeutic use | Ebolavirus - genetics | Reverse Transcriptase Polymerase Chain Reaction | Viral Load | Feasibility Studies | Young Adult | Hemorrhagic Fever, Ebola - diagnosis | Adolescent | Adult | Female | Historically Controlled Study | Child | Hemorrhagic Fever, Ebola - drug therapy | Antiviral agents | Ebola virus infections | Drug therapy | Patient outcomes | Care and treatment | RNA | Mortality | Genomics | Clinical trials | Hostages | Biosafety | Oral medication | Ethical aspects | Non-governmental organizations | Ebola virus | Virus diseases | Analysis | Health aspects | Studies | Epidemics | Life Sciences | Social Anthropology and ethnology | Humanities and Social Sciences
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 03/2019, Volume 19, Issue 3, pp. 308 - 316
The prevalence of Ebola virus infection among people who have been in contact with patients with Ebola virus disease remains unclear, but is essential to...
INFECTIOUS DISEASES | RISK-FACTORS | LATENT CLASS ANALYSIS | MODELS | DISEASE | SEQUELAE | Ebola virus | Virus diseases | Medical research | Disease transmission | Medical examination | Analysis | Medicine, Experimental | Ebola virus infections | Health aspects | Blood donors | Blood | Prevalence studies (Epidemiology) | Participation | Epidemics | Vaccination | Viral diseases | Viruses | Population studies | Infections | Risk factors | Antibody response | Proteins | Ultrasonic testing | Cross sections | Antigens | Signs and symptoms | Blood & organ donations | Households | Glycoprotein | Glycoproteins | Exposure | Risk analysis | Studies | Body fluids | Dynamic tests | Medical centres
INFECTIOUS DISEASES | RISK-FACTORS | LATENT CLASS ANALYSIS | MODELS | DISEASE | SEQUELAE | Ebola virus | Virus diseases | Medical research | Disease transmission | Medical examination | Analysis | Medicine, Experimental | Ebola virus infections | Health aspects | Blood donors | Blood | Prevalence studies (Epidemiology) | Participation | Epidemics | Vaccination | Viral diseases | Viruses | Population studies | Infections | Risk factors | Antibody response | Proteins | Ultrasonic testing | Cross sections | Antigens | Signs and symptoms | Blood & organ donations | Households | Glycoprotein | Glycoproteins | Exposure | Risk analysis | Studies | Body fluids | Dynamic tests | Medical centres
Journal Article